Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Graft vs Host Disease | 15 | 2024 | 3026 | 1.690 |
Why?
|
Thalidomide | 1 | 2021 | 884 | 0.510 |
Why?
|
Hematopoietic Stem Cell Transplantation | 9 | 2024 | 5659 | 0.470 |
Why?
|
Salvage Therapy | 1 | 2021 | 1268 | 0.460 |
Why?
|
Immunologic Factors | 1 | 2021 | 1588 | 0.390 |
Why?
|
Immunosuppressive Agents | 3 | 2024 | 4167 | 0.350 |
Why?
|
Eye Diseases | 1 | 2015 | 651 | 0.340 |
Why?
|
Interleukin-2 | 1 | 2016 | 1889 | 0.330 |
Why?
|
Joints | 2 | 2021 | 321 | 0.270 |
Why?
|
Chronic Disease | 12 | 2024 | 9288 | 0.260 |
Why?
|
Cardiac Output | 5 | 2005 | 838 | 0.210 |
Why?
|
Cyclosporine | 1 | 2024 | 777 | 0.200 |
Why?
|
Cardiac Pacing, Artificial | 5 | 2005 | 866 | 0.190 |
Why?
|
Tacrolimus | 1 | 2024 | 733 | 0.180 |
Why?
|
Heart Block | 4 | 2005 | 392 | 0.180 |
Why?
|
Lymphocyte Subsets | 1 | 2021 | 310 | 0.170 |
Why?
|
Models, Biological | 1 | 2015 | 9468 | 0.160 |
Why?
|
Lymphopenia | 1 | 2021 | 280 | 0.160 |
Why?
|
Lymphocyte Count | 1 | 2021 | 780 | 0.160 |
Why?
|
Methotrexate | 1 | 2024 | 1718 | 0.150 |
Why?
|
Sirolimus | 1 | 2024 | 1547 | 0.140 |
Why?
|
Hematologic Neoplasms | 4 | 2024 | 1901 | 0.130 |
Why?
|
Drug Resistance | 1 | 2021 | 1617 | 0.120 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1792 | 0.110 |
Why?
|
Fascia | 1 | 2014 | 141 | 0.110 |
Why?
|
Fatigue | 1 | 2021 | 1544 | 0.110 |
Why?
|
Guanidines | 2 | 2005 | 193 | 0.110 |
Why?
|
Pulmonary Valve Stenosis | 2 | 2004 | 172 | 0.110 |
Why?
|
Kaplan-Meier Estimate | 2 | 2021 | 6544 | 0.100 |
Why?
|
Sulfones | 2 | 2005 | 447 | 0.100 |
Why?
|
Transplantation, Homologous | 4 | 2024 | 4815 | 0.090 |
Why?
|
Aftercare | 1 | 2017 | 916 | 0.090 |
Why?
|
Immunoglobulin E | 1 | 2017 | 1484 | 0.090 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2005 | 784 | 0.090 |
Why?
|
Liver Diseases | 1 | 2018 | 1302 | 0.080 |
Why?
|
Young Adult | 7 | 2024 | 58748 | 0.080 |
Why?
|
Adolescent | 7 | 2021 | 87809 | 0.080 |
Why?
|
Severity of Illness Index | 2 | 2018 | 15840 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2021 | 10826 | 0.080 |
Why?
|
Bone Marrow Transplantation | 1 | 2016 | 2693 | 0.080 |
Why?
|
Range of Motion, Articular | 1 | 2014 | 1583 | 0.070 |
Why?
|
Bone Density | 2 | 2018 | 3534 | 0.070 |
Why?
|
Aged | 9 | 2024 | 169143 | 0.070 |
Why?
|
Skin | 1 | 2021 | 4466 | 0.070 |
Why?
|
Adult | 11 | 2024 | 220007 | 0.070 |
Why?
|
Vitamin D Deficiency | 1 | 2016 | 1379 | 0.070 |
Why?
|
Osteoporosis | 1 | 2016 | 1601 | 0.070 |
Why?
|
Middle Aged | 10 | 2024 | 220359 | 0.070 |
Why?
|
Autoantibodies | 1 | 2014 | 2119 | 0.060 |
Why?
|
Probucol | 1 | 2005 | 25 | 0.060 |
Why?
|
Transplantation Conditioning | 2 | 2024 | 1593 | 0.060 |
Why?
|
Cytokines | 1 | 2020 | 7344 | 0.060 |
Why?
|
Ventricular Fibrillation | 2 | 2005 | 539 | 0.060 |
Why?
|
Child | 6 | 2020 | 79799 | 0.060 |
Why?
|
Male | 14 | 2024 | 359718 | 0.060 |
Why?
|
Cross-Sectional Studies | 6 | 2022 | 25941 | 0.060 |
Why?
|
Sus scrofa | 4 | 2005 | 433 | 0.050 |
Why?
|
Leukapheresis | 1 | 2022 | 134 | 0.050 |
Why?
|
Vitamin D | 1 | 2016 | 3291 | 0.050 |
Why?
|
Predictive Value of Tests | 2 | 2016 | 15286 | 0.050 |
Why?
|
Female | 11 | 2024 | 391246 | 0.050 |
Why?
|
Prospective Studies | 4 | 2021 | 54306 | 0.050 |
Why?
|
Humans | 16 | 2024 | 760613 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2014 | 4742 | 0.050 |
Why?
|
Iatrogenic Disease | 1 | 2003 | 538 | 0.040 |
Why?
|
Child, Preschool | 3 | 2018 | 42056 | 0.040 |
Why?
|
Ethanol | 1 | 2005 | 1323 | 0.040 |
Why?
|
Quality of Life | 1 | 2021 | 13308 | 0.040 |
Why?
|
Reperfusion Injury | 1 | 2005 | 1023 | 0.040 |
Why?
|
Monitoring, Intraoperative | 1 | 2005 | 942 | 0.040 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2018 | 296 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 2014 | 10181 | 0.040 |
Why?
|
Antioxidants | 1 | 2005 | 1667 | 0.040 |
Why?
|
Electrocardiography | 3 | 2005 | 6415 | 0.030 |
Why?
|
Croatia | 1 | 2016 | 34 | 0.030 |
Why?
|
Heart Ventricles | 2 | 2004 | 3812 | 0.030 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2005 | 1582 | 0.030 |
Why?
|
Hemodynamics | 1 | 2005 | 4173 | 0.030 |
Why?
|
Defibrillators, Implantable | 1 | 2003 | 1499 | 0.030 |
Why?
|
Platelet Count | 1 | 2016 | 777 | 0.030 |
Why?
|
Blood Pressure | 2 | 2005 | 8525 | 0.030 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 693 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2005 | 3224 | 0.020 |
Why?
|
Swine | 3 | 2005 | 5899 | 0.020 |
Why?
|
Heart Rate | 3 | 2005 | 4180 | 0.020 |
Why?
|
Uric Acid | 1 | 2014 | 807 | 0.020 |
Why?
|
Lung Diseases | 1 | 2018 | 1915 | 0.020 |
Why?
|
Nutritional Status | 1 | 2016 | 1607 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39262 | 0.020 |
Why?
|
Prognosis | 2 | 2017 | 29661 | 0.020 |
Why?
|
Compliance | 1 | 2005 | 100 | 0.020 |
Why?
|
Transplantation, Isogeneic | 1 | 2005 | 248 | 0.020 |
Why?
|
Transplantation, Heterotopic | 1 | 2005 | 174 | 0.020 |
Why?
|
Pressoreceptors | 1 | 2005 | 100 | 0.020 |
Why?
|
Cardiac Volume | 1 | 2005 | 199 | 0.010 |
Why?
|
Antigens, CD | 1 | 2014 | 4000 | 0.010 |
Why?
|
Thoracotomy | 1 | 2005 | 363 | 0.010 |
Why?
|
Atrioventricular Node | 1 | 2004 | 180 | 0.010 |
Why?
|
Survival Analysis | 1 | 2016 | 10185 | 0.010 |
Why?
|
Rats, Inbred Lew | 1 | 2005 | 1154 | 0.010 |
Why?
|
Cohort Studies | 2 | 2016 | 41337 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2014 | 4542 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9278 | 0.010 |
Why?
|
Comorbidity | 1 | 2017 | 10553 | 0.010 |
Why?
|
Animals | 8 | 2005 | 167960 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 2005 | 1628 | 0.010 |
Why?
|
Vena Cava, Inferior | 1 | 2005 | 458 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 8055 | 0.010 |
Why?
|
Disease Models, Animal | 3 | 2005 | 18137 | 0.010 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2004 | 355 | 0.010 |
Why?
|
Ventricular Function, Right | 1 | 2004 | 610 | 0.010 |
Why?
|
Organ Size | 1 | 2005 | 2254 | 0.010 |
Why?
|
Risk Factors | 2 | 2018 | 74333 | 0.010 |
Why?
|
Electrodes, Implanted | 1 | 2004 | 833 | 0.010 |
Why?
|
Models, Animal | 1 | 2005 | 2117 | 0.010 |
Why?
|
Respiration | 1 | 2005 | 1654 | 0.010 |
Why?
|
Models, Cardiovascular | 1 | 2004 | 977 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7475 | 0.010 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2004 | 615 | 0.010 |
Why?
|
Asthma | 1 | 2017 | 6172 | 0.010 |
Why?
|
Heart Atria | 1 | 2004 | 1346 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 40139 | 0.010 |
Why?
|
Reaction Time | 1 | 2004 | 2075 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 2005 | 20080 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2005 | 6498 | 0.010 |
Why?
|
Linear Models | 1 | 2005 | 5877 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2021 | 80345 | 0.010 |
Why?
|
Echocardiography | 1 | 2004 | 4981 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2014 | 13627 | 0.010 |
Why?
|
Ventricular Function, Left | 1 | 2004 | 3880 | 0.010 |
Why?
|
Stroke Volume | 1 | 2004 | 5523 | 0.010 |
Why?
|
United States | 1 | 2018 | 72448 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2004 | 14661 | 0.000 |
Why?
|
Rats | 1 | 2005 | 23709 | 0.000 |
Why?
|
Treatment Outcome | 2 | 2005 | 64981 | 0.000 |
Why?
|
Heart Failure | 1 | 2004 | 11848 | 0.000 |
Why?
|
Concepts
(136)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_